Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Hepatology

• Publication date

  1995-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0168-8278(95)80291-6PMID 7608489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Auto-immune thrombocytopenia related to interferon therapy.

  2009cited by this paper
• Hepatitis C virus infection in anti-HIV positive and negative French homosexual men with chronic hepatitis: comparison of second- and third-generation anti-HCV testing.

  2008cited by this paper
• Anti-GOR and anti-thyroid autoantibodies in patients with chronic hepatitis C.

  1995cited by this paper
• Immunological disorders in C virus chronic active hepatitis: A prospective case‐control study

  1994cited by this paper
• Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon

  1994cited by this paper
• [Disclosure of autoimmune hepatitis by interferon].

  1993cited by this paper
• Latent autoimmune thyroid disease in patients with chronic HCV hepatitis.

  1993cited by this paper
• High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies.

  1993cited by this paper
• Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C

  1993cited by this paper
• Cryoglobulinemia with vasculitis associated with hepatitis C virus infection.

  1993cited by this paper
• High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy

  1993cited by this paper
• [Autoimmune dysthyroidism induced by alpha interferon in two female patients with chronic non-A, non-B hepatitis].

  1993cited by this paper
• Hépatite auto-immune de type 1 révélée par un traitement par interféron.

  1992cited by this paper
• Hepatitis C virus and Hashimoto's thyroiditis.

  1992cited by this paper
• Prevalence of anti-thyroid peroxidase antibodies in serum in the elderly: comparison with other tests for anti-thyroid antibodies.

  1992cited by this paper
• A role for hepatitis C virus infection in type II cryoglobulinemia.

  1992cited by this paper
• Liver/kidney microsome antibody type 1 and hepatitis C virus infection

  1992cited by this paper
• [Autoimmune hepatitis type 1 revealed during treatment with interferon].

  1992cited by this paper
• Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.

  1992cited by this paper
• Cities, winter birth, and schizophrenia.

  1992cited by this paper
• Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

  1992cited by this paper
• Latent autoimmune thyroid disease in patients with chronic HCV hepatitis.

  1992cited by this paper
• Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa.

  1992cited by this paper
• Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis.

  1992cited by this paper
• Autoimmune Chronic Hepatitis Exacerbated by Alpha-Interferon

  1992cited by this paper
• Does Interferon-β Therapy Induce Thyroid Autoimmune Phenomena?

  1991cited by this paper
• Reversible thyroid dysfunction during treatment with GM-CSF.

  1991cited by this paper
• Recombinant human α‐interferon in patients with chronic non‐A, non‐B hepatitis: A multicenter randomized controlled trial from France

  1991cited by this paper
• The interferons. Mechanisms of action and clinical applications.

  1991cited by this paper
• LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.

  1991cited by this paper
• Does interferon-beta therapy induce thyroid autoimmune phenomena?

  1991cited by this paper
• Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.

  1991cited by this paper
• Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis

  1991cited by this paper
• Possible induction of systemic lupus erythematosus by interferon‐α treatment in a patient with a malignant carcinoid tumour

  1990cited by this paper
• Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

  1990cited by this paper
• Antithyroid peroxidase autoantibodies in thyroid diseases.

  1990cited by this paper
• Thyroiditis after treatment with interleukin-2 and interferon alpha-2a.

  1990cited by this paper
• Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

  1989cited by this paper
• Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

  1989cited by this paper
• Treatment of chronic type B hepatitis with recombinant α‐interferon induces autoantibodies not specific for autoimmune chronic hepatitis

  1989cited by this paper
• Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

  1989cited by this paper
• Induction of hyperthyroidism by interferon-alpha-2b.

  1989cited by this paper
• Hypothyroidism and goitre during interleukin-2 therapy without LAK cells.

  1989cited by this paper
• Recombinant alfa‐2B‐interferon therapy in untreated, stages A and B chronic lymphocytic leukemia. A preliminary report

  1988cited by this paper
• An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer.

  1988cited by this paper
• Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells.

  1988cited by this paper
• Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon.

  1986cited by this paper
• Primary hypothyroidism associated with interferon therapy of breast cancer.

  1985cited by this paper
• Thyroid antibodies in blood donors: prevalence and clinical significance.

  1984cited by this paper
• Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

  1979cited by this paper
• Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.

  1978cited by this paper
• Increased spreading of macrophages from mice treated with interferon inducers.

  1977cited by this paper

• Exploring causal links between autoimmune liver diseases, chronic hepatitis C, and thyroid disorders: Evidence from NHANES and GWAS studies

  2025cites this paper
• Thyroid Function Indices ( T 3 , T 4 , a-Tpo , Tg , aTg ) During Hepatitis B in Khoy City , İran , Before Alpha-Interferon Therapy

  2019cites this paper
• Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment.

  2016cites this paper
• Pretreatment Evaluation of Chronic Hepatitis C

  2015cites this paper
• DEPRESSION AND INTERFERON THERAPY IN CHRONIC HEPATITIS C PATIENTS DEPRESSION AND INTERFERON THERAPY IN CHRONIC HEPATITIS C PATIENTS: EPIDEMIOLOGY, PREDIC- TIVE FACTORS AND PROPOSED ETIOPATHOGENIC MODELS

  2015cites this paper
• DURING COMBINED PEG-INTERFERON ALPHA-2A AND RIBAVIRIN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C

  2015cites this paper
• Etude de la variabilité génétique des régions NS3, NS5A et NS5B du virus de l'hépatite C chez des patients Tunisiens non traités

  2015cites this paper
• Autoantibodies in chronic hepatitis C: A clinical perspective.

  2015cites this paper
• LE CAS CLINIQUE DU MOIS Hyperthyroïdie induite par interféron alpha : rapport d'un cas et revue de la littérature

  2015cites this paper
• Frequency of Thyroid Dysfunctions during Interferon Alpha Treatment of Single and Combination Therapy in Hepatitis C Virus-Infected Patients: A Systematic Review Based Analysis

  2013cites this paper
• Thyroid Dysfunction and Autoimmunity Among Patients with Chronic Hepatitis C Receiving Interferon-α Therapy

  2013cites this paper
• Hepatitis C virus infection in patients with primary biliary cirrhosis.

  2013cites this paper
• Thyroid Function Abnormalities in Patients Receiving Anticancer Agents

  2012cites this paper
• Organ-Specific Autoimmunity in HCV-Positive Patients

  2012cites this paper
• P UNIVERSIDADE FEDERAL DO PARÁ NÚCLEO DE MEDICINA TROPICAL PROGRAMA DE PÓS-GRADUAÇÃO EM DOENÇAS TROPICAIS

  2012cites this paper
• Thyroid dysfunction from antineoplastic agents.

  2011cites this paper
• The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.

  2011influential citation
• Manifestations extrahépatiques au cours de l'infection par le virus de l'hépatite C

  2010cites this paper
• Thyroid Disorders in Hepatitis C Patients Treated or Not With α-Interferon and Ribavirin

  2010cites this paper
• Hepatitis C Virus as a Multifaceted Disease: A Simple and Updated Approach for Extrahepatic Manifestations of Hepatitis C Virus Infection

  2010cites this paper
• INTERFERON-ALPHA SIGNALING PATHWAY IN THE SENSORY AUDITORY NEUROEPITHELIAL CELLS

  2010cites this paper
• Thyroid Dysfunction in Patients with Chronic Viral Hepatitis B and C during Alpha Interferon Therapy

  2009influential citation
• Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin--a review.

  2008cites this paper
• Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection

  2008cites this paper
• Traitement de l'hépatite C

  2008cites this paper
• Hepatitis C Infection, Treatment Regimens, and Thyroid Function Abnormalities

  2007cites this paper
• Hepatitis C Virus Infection is Probably Associated with Autoimmune Disorders and Malignancies but not with Autoimmune Thyroiditis

  2007cites this paper
• Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations

  2007cites this paper
• [Treatment of chronic hepatitis B].

  2006cites this paper
• Traitement de l’hépatite chronique B

  2006cites this paper
• The Incidence and Evolution of Thyroid Dysfunction During Interferon-α Therapy in Children with Chronic Hepatitis Β Infection

  2006cites this paper
• Hépatite C et transplantation hépatique. Histoire naturelle et traitement ou comment améliorer la prise en charge

  2006cites this paper
• [Hepatitis C and liver transplantation: fibrosis progression and treatment. Or how to improve management].

  2006cites this paper
• Untersuchung zu Reaktionen der Schilddrüse auf eine tägliche Interferontherapie bei chronischer Hepatitis C

  2006cites this paper
• Is hepatitis C virus a risk factor for thyroid autoimmunity?

  2006cites this paper
• Serum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV-Genotype 4 Chronic Hepatitis

  2006cites this paper
• Auto-anticorps et pathologies hépatiques

  2006cites this paper
• Susceptibility to thyroid disorders in hepatitis C.

  2005cites this paper
• Graves' Disease in Interferon-α-Treated and Untreated Patients with Chronic Hepatitis C Virus Infection

  2005cites this paper
• [Chronic hepatitis B: which patients should be treated and how?].

  2005cites this paper
• Evidence-informed assessment and treatment of depression in HCV and interferon-treated patients

  2005cites this paper
• Is Steroid Therapy Needed in the Treatment of Destructive Thyrotoxicosis Induced by α-Interferon in Chronic Hepatitis C?

  2005cites this paper
• Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study.

  2004cites this paper
• [Treatment of chronic hepatitis B].

  2004cites this paper
• Diagnostik und Therapie der akuten und chronischen Hepatitis C - Vorgehen in Problemsituationen

  2004cites this paper
• Thyroid autoimmunity and dysfunction associated with type I interferon therapy

  2004cites this paper
• [Diagnosis and treatment of acute and chronic hepatitis C--procedure in difficult situations].

  2004cites this paper
• Traitement de l’hépatite chronique B

  2004cites this paper
• Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection.

  2003cites this paper
• Extrahepatic manifestations of hepatitis C infection.

  2003cites this paper
• Comprehensive Review of Hepatitis C for Psychiatrists: Risks, Screening, Diagnosis, Treatment, and Interferon-Based Therapy Complications

  2003cites this paper
• Interferon-α and Autoimmune Thyroid Disease

  2003cites this paper
• Traitement de l'hépatite C

  2003cites this paper
• Interferon-alpha and autoimmune thyroid disease.

  2003cites this paper
• Cost effectiveness of combination therapy for hepatitis C: a decision analytic model

  2002cites this paper
• Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapy

  2002cites this paper
• Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy

  2002cites this paper
• Autoantibodies in Multiple Sclerosis Patients Before and During IFN-β1b Treatment: Are They Correlated with the Occurrence of Autoimmune Diseases?

  2002cites this paper
• Fatigue in patients with chronic hepatitis C

  2002cites this paper
• [Treatment of extrahepatic manifestations associated with hepatitis C virus infection].

  2002cites this paper
• Thyrotoxicosis induced by alpha‐interferon therapy in chronic viral hepatitis

  2002cites this paper
• Hepatitis C: Who Should You Treat and How?

  2002cites this paper
• Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations.

  2001cites this paper
• Iodine-Induced Hypothyroidism

  2001cites this paper
• Usefulness of a Liver Biopsy in the Evaluation of Patients with Elevated ALT Values and Serological Markers of Hepatitis Viral Infection

  2001cites this paper
• Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.

  2001cites this paper
• Hepatitis C and D, retroviruses and autoimmune manifestations.

  2001cites this paper
• Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.

  2001cites this paper
• Tolerability of Treatments for Viral Hepatitis

  2001cites this paper
• Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.

  2001cites this paper
• Autoimmune hepatitis and its variant syndromes

  2001cites this paper
• Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study.

  2001cites this paper
• Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C

  2001cites this paper
• [Interferon and plasma lipids].

  2000cites this paper
• Interferone e tireopatie

  2000cites this paper
• Treatment of autoimmune and extra-hepatic manifestations of HCV infection.

  2000cites this paper
• Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.

  2000cites this paper
• Hepatitis C: an update on the silent epidemic.

  2000cites this paper
• Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study.

  2000cites this paper
• Hepatitis C Virus, Autoimmunity and Cancer

  2000cites this paper
• Virus, liver and autoimmunity.

  2000cites this paper
• Interferón y lípidos plasmáticos

  2000cites this paper
• Natural history of HCV infection.

  2000cites this paper
• Extrahepatic manifestations of chronic hepatitis C

  1999cites this paper
• Hepatitis C: the clinical spectrum of the disease.

  1999cites this paper
• Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection.

  1999cites this paper
• Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study

  1999cites this paper
• Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.

  1999cites this paper
• Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.

  1999cites this paper
• [Hepatitis C virus infection and thyroid diseases].

  1999cites this paper
• Autoimmune events during interferon beta-1b treatment for multiple sclerosis.

  1999cites this paper
• Viral genotypes as determinants of autoimmune expression in chronic hepatitis C.

  1999cites this paper
• Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis.

  1999cites this paper
• [Autoantibodies in hepatology].

  1999cites this paper
• Infection par le virus de l'hépatite C et pathologies thyroïdiennes

  1999cites this paper
• Manifestations extrahépatiques associées au virus de l'hépatite C

  1999cites this paper
• Recombinant interferon α (rIFN‐α) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis

  1999influential citation
• Hepatitis C Virus and Autoimmunity

  1999cites this paper
• Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.

  1998cites this paper
• Interleukin-6 Levels are not Increased in Women with Postpartum Thyroid Dysfunction

  1998cites this paper